2015-05-30-世界卫生组织-Consultation_for_the_South-East_Asia_Regional_Office_in_New_Delhi,_India,_28–29_April_2014_13页_368kb

Malaria 2025: Accelerate to Eliminate

Report on South East Asia Regional Consultation

Background

• Global Technical Strategy (GTS) for Malaria (2016-2025) was developed following Member State requests, with inclusive regional consultations.
• The focus of the SEA Regional Consultation (April 28-29, 2014, New Delhi) addressed unique epidemiological features of the region, including mixed P. falciparum and P. vivax transmission, urban malaria, and challenges like resistance and hard-to-reach populations.

Objectives & Outcomes

• Key Objectives: Share lessons learned, provide technical inputs, and discuss actions to accelerate malaria elimination.
• Expected Outcomes:
  • Consolidated inputs to refine the GTS.
  • Defined strategic priorities for the 2016-2025 period.
  • Identified challenges and recommendations for global collaboration and regional adaptation.

Key Recommendations & Strategic Directions

Challenges

1. Cross-border issues: Mobile populations, refugees, and border-related transmission require attention.
2. Urban malaria, insecticide and drug resistance, and wild malaria transmission were identified as critical barriers.

Core Values & Vision

• Core Values: Emphasize evidence-based policies, universal access, and multi-sectoral collaboration.
• Vision: Achieve global eradication by 2025, with regional elimination targets for 20 countries.

Strategic Directions

1. Surveillance & Response:

   • Strengthen data collection, predictive surveillance, and cross-border information sharing.
   • Address quality of data and sentinel systems like Early Warning.

2. Vector Control

   • Optimize tools (IRS, LLINs) and address outdoor transmission.
   • Build capacity for entomologists and integrated vector management.

3. Medicines & Diagnostics

   • Prioritize strategies for vivax malaria, relapse prevention, and mass drug administration (MDA).
   • Expand point-of-care diagnostics and address drug resistance.

4. T3: Test-Treat-Track

   • Enhance microscopy, track adherence for P. vivax, and ensure direct observation therapy.

5. Innovation & Research

   • Prioritize R&D for diagnostics, vector control, and vaccines tailored to SEA.

6. Health Systems Strengthening

   • Incorporate community mobilization, supply chain management, and political commitment.

Conclusion

• The SEA consultation provided regional inputs to align the GTS with local needs, emphasizing the need for harmonized frameworks, enhanced surveillance, and multi-sectoral partnerships for successful malaria elimination.